Recordati announces the appointment of Mike McClellan as Chief Financial Officer, aiming to leverage his extensive experience in the pharmaceutical industry to drive growth from its headquarters in Milan.
- Effective January 1, 2026, Mike McClellan will assume the role of Chief Financial Officer at Recordati, a key player in the pharmaceutical industry.
- McClellan brings nearly 30 years of experience, having recently served as CFO of Almirall from 2019 to 2025, enhancing his expertise in financial leadership.
- The appointment in Milan is part of Recordatis strategy to strengthen its financial management and expand its market presence, particularly in North America and Europe.
Por Qué Es Relevante
The selection of Mike McClellan as Chief Financial Officer reflects Recordatis commitment to strategic growth in the competitive pharmaceutical industry, positioning the company for future success in global markets.